Fierce Pharma February 20, 2024
Nick Paul Taylor

Senators are urging the FDA to address the “alarming proliferation of dangerous and misleading content promoting prescription drugs.” The lawmakers cited changes to social media, the rise of influencers and promotion by telehealth companies as evidence that the agency needs to act.

Richard Durbin, D-Illinois, and Mike Braun, R-Indiana, wrote (PDF) to FDA Commissioner Robert Califf, M.D., after seeing several signs that the agency needs to “take swift action to update its enforcement tools to reflect the current platforms and methods used to promote prescription drugs and biologics, and to prioritize the protection of children from harmful and inaccurate medical advice.”

The senators claim advertisers are exploiting the holes in FDA’s oversight on social media at the expense of children...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Pharma, Pharma / Biotech
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
HHS Explores Stronger FDA Oversight for Food Ingredients

Share This Article